We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWH icon
3076
Camping World
CWH
$635M
$254K ﹤0.01%
+28,485
New +$275K
IGD
3077
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$522M
$254K ﹤0.01%
42,289
+14,125
+50% +$90.6K
OPCH icon
3078
Option Care Health
OPCH
$3.67B
$254K ﹤0.01%
19,875
-6,950
-26% -$85.5K
SVM
3079
Silvercorp Metals
SVM
$2.7B
$254K ﹤0.01%
65,408
+53,549
+452% +$192K
WTRE icon
3080
WisdomTree New Economy Real Estate Fund
WTRE
$15.5M
$254K ﹤0.01%
+8,686
New +$257K
KAMN
3081
DELISTED
Kaman Corp
KAMN
$253K ﹤0.01%
4,261
+348
+9% +$20.9K
MXI icon
3082
iShares Global Materials ETF
MXI
$363M
$252K ﹤0.01%
4,017
-244
-6% -$15.2K
PRTK
3083
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$252K ﹤0.01%
58,323
-25,800
-31% -$103K
NAN icon
3084
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$251K ﹤0.01%
17,613
+7,368
+72% +$104K
VICR icon
3085
Vicor
VICR
$9.63B
$251K ﹤0.01%
8,500
-4,000
-32% -$123K
AUD
3086
DELISTED
Audacy, Inc.
AUD
$251K ﹤0.01%
75,139
-261,282
-78% -$1.17M
CELP
3087
DELISTED
Cypress Environmental Partners, L.P.
CELP
$251K ﹤0.01%
27,857
ISCG icon
3088
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.01B
$250K ﹤0.01%
7,716
-1,008
-12% -$34.1K
MIK
3089
DELISTED
Michaels Stores, Inc
MIK
$250K ﹤0.01%
25,568
-50,698
-66% -$379K
LKFT
3090
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$249K ﹤0.01%
+1,634
New +$268K
GT icon
3091
Goodyear
GT
$1.74B
$249K ﹤0.01%
17,283
-2,563
-13% -$34.1K
SOS
3092
SOS Limited
SOS
$14.4M
$249K ﹤0.01%
64
-4
-6% -$16K
CBAY
3093
DELISTED
Cymabay Therapeutics
CBAY
$249K ﹤0.01%
48,590
-5,703
-11% -$34.5K
OMP
3094
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$249K ﹤0.01%
+15,571
New +$283K
VRAY
3095
DELISTED
ViewRay, Inc.
VRAY
$248K ﹤0.01%
85,650
+61,850
+260% +$366K
EBS icon
3096
Emergent Biosolutions
EBS
$229M
$247K ﹤0.01%
+4,718
New +$220K
MDT icon
3097
CALL
Medtronic
MDT
$114B
$246K ﹤0.01%
83,000
-20,300
-20% -$2.12M
MKC.V icon
3098
McCormick & Company Voting
MKC.V
$14B
$246K ﹤0.01%
3,156
+12
+0.4% +$964
ARWR icon
3099
Arrowhead Research
ARWR
$12.5B
$245K ﹤0.01%
+8,707
New +$258K
AXU
3100
DELISTED
Alexco Resource Corp
AXU
$245K ﹤0.01%
140,280
+36,555
+35% +$67.3K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.